Emerald Kalama Chemical

Photo

Lanxess to Acquire Emerald Kalama Chemical

Germany’s Lanxess has signed a binding agreement to acquire 100% of Emerald Kalama Chemical from affiliates of private equity firm American Securities. The US specialty chemicals producer focused mainly on consumer markets last reported sales of $425 million and EBITDA pre-exceptionals of $90 million. Closing is expected in the second half of 2021, subject to regulatory approval.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.